Case study

EPIGRAL

Meghmani Finechem

Mixed signals1y model +0.1%

Each stock's 10,000-path forecast, rendered as light.

52Score

Meghmani Finechem (EPIGRAL) Stock Analysis & Case Study

Is EPIGRAL a good buy? The data-driven verdict.

Meghmani Finechem (EPIGRAL) trades at ₹1,127,on the numbers it mixed signals, a Downstox Snapshot Score of 52/100.

On the numbers, Meghmani Finechem (EPIGRAL) mixed signals, a Downstox Snapshot Score of 52/100, weighing fairly valued at 17.9× earnings, ROE of 16.0%, a 50% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.

Last updated . Data snapshot for research, not investment advice.

EPIGRAL fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield

Market cap
₹4,858 Cr
Current price
₹1,127
P/E ratio
17.9×
P/B ratio
2.19×
Book value
₹515
Dividend yield
0.44%
ROCE
15.5%
ROE
16.0%
Piotroski F-Score
5/8

How EPIGRAL ranks against the 2,374 companies in our screener

Is EPIGRAL overvalued? EPIGRAL P/E vs peers

EPIGRAL trades at 17.9× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.

EPIGRAL share price target 2027, 2028, 2029, 2030, 2031, a probability view

Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 4.9y of EPIGRAL history (20%/yr drift, 47%/yr volatility).

YearLow (P10)Median target (P50)High (P90)Upside vs today
EPIGRAL 2027₹609₹1,102₹1,994+0%
EPIGRAL 2028₹472₹1,103₹2,575+0%
EPIGRAL 2029₹389₹1,104₹3,135+0%
EPIGRAL 2030₹331₹1,105₹3,687+0%
EPIGRAL 2031₹282₹1,106₹4,331+0%

Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.

What is the probability EPIGRAL goes up, or doubles?

50%
Higher in 1 year
Modelled chance the price is above today in 12 months
50%
Higher in 5 years
Modelled chance the price is above today in 5 years
26%
Doubles in 5 years
Modelled chance of reaching ₹2,202 within 5 years

The bull case for EPIGRAL

  • EPIGRAL's P/E of 17.9x is lower than 67% of the 2,374 NSE companies in our screener, as of 10 Aug 2026.
  • EPIGRAL's return on equity of 16.0% ranks in the 75th percentile of the 2,374 NSE companies in our screener, as of 10 Aug 2026.
  • Upside scenario: the model's optimistic (P90) 3-year path reaches ₹3,135.

The bear case & risks

  • High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
  • Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹389.

EPIGRAL volatility & expected range, how bumpy is the ride?

Over the last 4.9 years EPIGRAL compounded at 20%/year with annualized volatility of 47%. That volatility implies a 1-year 80% range of ₹609-₹1,994, the honest backbone behind any single price target.

EPIGRAL price forecast, the full 60-month probability fan

Spot Price · Today
₹0
Based on 4.9 years of daily NSE data ·0.0% annualised volatility
5-yr median forecast
₹0
P(price ↑ in 5y)
0%
1-Year Forecast
2027
₹0
Median (P50)
0.1%
80% range₹609-₹1,994
P(price ↑)50%
P(price 2×)7%
3-Year Forecast
2029
₹0
Median (P50)
0.2%
80% range₹389-₹3,135
P(price ↑)50%
P(price 2×)20%
5-Year Forecast
2031
₹0
Median (P50)
0.4%
80% range₹282-₹4,331
P(price ↑)50%
P(price 2×)26%

EPIGRAL price probability fan

Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.

Probability Fan
EPIGRAL simulated paths · 60 months · 10,000 trials
P10-P90 (80%)P25-P75 (50%)Median (P50)

Probability of key outcomes

What are the odds EPIGRAL hits common targets within the simulated horizon?

0%
P(↑ 1Y)
Above today's price in 1 year
0%
P(↑ 5Y)
Above today's price in 5 years
0%
P(2×)
Doubles within 5 years
0%
P(↓)
Falls below today in 5 years

Full multi-horizon detail on the EPIGRAL price target & forecast page.

EPIGRAL Piotroski F-Score: 5/8, how financially strong is it?

5/8

The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. EPIGRAL scores 5/8, mixed financial health.

EPIGRAL MTF margin & leverage across 9 brokers

Margin Trading Facility lets you buy EPIGRAL with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):

BrokerMargin requiredApprox. leverage
Upstox35.58%2.8×
ZerodhaCHEAPEST35.54%2.8×
Groww35.67%2.8×
Dhan35.54%2.8×
Paytm Money38.54%2.6×
Pocketful35.66%2.8×
Anand RathiCHEAPEST35.54%2.8×
Bajaj Broking40.00%2.5×
Share India35.67%2.8×

Compare every broker on the EPIGRAL MTF page.

About Meghmani Finechem: sector, index & market-cap context

Meghmani Finechem (EPIGRAL) is a small-cap NSE-listed company, with a market capitalisation of ₹4,858 Cr. See more stocks on our screener.

How the EPIGRAL Snapshot Score & forecast are built

The Downstox Snapshot Score is a transparent, rules-based read of Meghmani Finechem's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.

This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.

EPIGRAL analysis, FAQs

Is Meghmani Finechem (EPIGRAL) a good buy?

On the numbers, Meghmani Finechem (EPIGRAL) mixed signals, a Downstox Snapshot Score of 52/100, weighing fairly valued at 17.9× earnings, ROE of 16.0%, a 50% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.

Is EPIGRAL overvalued or undervalued?

EPIGRAL trades at 17.9× earnings, fairly valued versus the ~22× long-run Nifty average.

What is the EPIGRAL share price target for 2031?

EPIGRAL's probability-weighted 2031 median target is ₹1,106, with an 80% range of ₹282-₹4,331 (10,000-path Monte-Carlo).

What is the probability EPIGRAL doubles in 5 years?

The modelled probability of EPIGRAL reaching ₹2,202 (2×) within 5 years is 26%.

What is the bull case for EPIGRAL?

EPIGRAL's P/E of 17.9x is lower than 67% of the 2,374 NSE companies in our screener, as of 10 Aug 2026. EPIGRAL's return on equity of 16.0% ranks in the 75th percentile of the 2,374 NSE companies in our screener, as of 10 Aug 2026.

What are the risks in EPIGRAL?

High historical volatility (47%/yr) means a wide, bumpy range of outcomes, size positions accordingly.

More on EPIGRAL